Randomized, double-blind, placebo (pbo)-controlled, single- and multiple-dose phase 1 study of ve202, a defined bacterial consortium for treatment of ibd: safety and colonization dynamics of a novel live biotherapeutic product (lbp) in healthy adults
INFLAMMATORY BOWEL DISEASES(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要